Physician profile
Scott Tinter
NPI 1245276757
$2,088.56
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $194 · 2021: $350 · 2022: $611.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $256.87 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $243.10 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.31 | 2019-2022 | |
| Astellas Pharma US INC | $199.59 | 2019-2022 | |
| Amgen INC. | $154.14 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.17 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $124.08 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $119.38 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $83.83 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $77.68 | 2021-2022 | |
| Amarin Pharma, INC. | $73.94 | 2019 | |
| Pfizer INC. | $55.60 | 2019-2022 | |
| Edwards Lifesciences Corporation | $49.50 | 2020-2022 | |
| Dynavax Technologies Corporation | $36.66 | 2021 | |
| Abbott Laboratories | $34.25 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $33.59 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $26.25 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $24.54 | 2019 | |
| Sanofi Pasteur INC. | $24.45 | 2020 | |
| Althera Pharmaceuticals LLC | $21.05 | 2021 | |
| Esperion Therapeutics, INC. | $17.33 | 2022 | |
| Boston Scientific Corporation | $14.47 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.42 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.36 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Tinter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.